Skip to content
10-K

Annual Report

CANCER CAPITAL CORP.

0001554795-23-000097

← back to feed
Filed
Mar 30, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · Mar 28, 2023 6.15M sh
Operating Cash Flow FY 2022 · Dec 31, 2021 −$12.34K
Cash And Equivalents FY 2022 · Dec 31, 2021 $62
Current Liabilities FY 2022 · Dec 31, 2021 $369.19K
Total Liabilities FY 2022 · Dec 31, 2021 $369.19K
Current Assets FY 2022 · Dec 31, 2021 $62
Total Assets FY 2022 · Dec 31, 2021 $62
Eps Basic FY 2022 · Dec 31, 2021 −$0.01
Sga Expense FY 2022 · Dec 31, 2021 $18.34K
Net Income FY 2022 · Dec 31, 2021 −$36.79K
Operating Income FY 2022 · Dec 31, 2021 −$18.34K
Stockholders Equity FY 2022 · Dec 31, 2020 −$332.34K